Obesity is a well-established risk factor for a broad spectrum of chronic diseases, including cardiovascular disease, diabetes, cancer, and liver disease.

Since the landmark approvals of lecanemab and donanemab, anti-amyloid immunotherapy has marked a paradigm shift in ...

Globally, metabolic dysfunction-associated steatotic liver disease (MASLD) is now the most common chronic liver disease, affecting up to one in three people in the general population, with an ...

For almost 80 years, the US Centers for Disease Control and Prevention (CDC) has been the nation's immune system, detecting threats early, coordinating rapid responses, and safeguarding population ...

New tools that create ultra-precise maps of our tissues are transforming our ability to diagnose and cure once-fatal ...

The intersection of climate change with chronic disease and healthcare infrastructure creates a critical and underreported ...

Accelerometer data from nearly 95,000 adults show that higher daily step counts predict lower short-term Parkinson’s disease ...

Results determined that farm type is the primary determinant of PRRSV transmission risk, accounting for 81% of the total ...

From obesity in cats and dogs and osteoarthritis in pigs, to cancer in whales and high blood glucose in racoons, chronic ...

Health officials have issued travel warnings as monkeypox outbreaks spread across multiple continents, with over 100,000 ...

Mixed headlines have plagued the cell and gene therapy space of late. We believe that a renewed case of optimism is not only ...

Kavita Nair, PhD, FAAN, shares how new therapies and ongoing clinical trials are reshaping the future of neurological care and offering new hope to patients.